Sign in

You're signed outSign in or to get full access.

Margaret Kane

Director at TRICO BANCSHARES /
Board

About Margaret L. Kane

Dr. Margaret L. Kane, age 69, has served on TriCo Bancshares’ Board since 2020 and is currently Chair of the Community Reinvestment Act (CRA) Committee, and a member of the IT/Cybersecurity and Risk Committees . She is President & CEO of Kane Bank Services, a financial services consultancy she founded in 1999, and previously was an Executive Vice President at Wells Fargo Bank, where she led the retail branch network and built the In-Store Banking Program (1988–1998) . The Board has affirmed independence for all directors other than the CEO, which includes Dr. Kane . Directors recorded a 97% aggregate attendance rate in 2024, with no nominee below 75% .

Past Roles

OrganizationRoleTenureCommittees/Impact
Kane Bank Services (KBS)President & CEO1999–presentConsulting to financial institutions on customer experience, distribution, training, and growth
Wells Fargo BankExecutive Vice President; Head of Retail Branch Network1988–1998Developed and managed the In-Store Banking Program from inception

External Roles

OrganizationRoleTenureNotes
Harvard Club of SacramentoBoard Member2011–presentCommunity and alumni leadership
Harvard Alumni AssociationExec. Committee (Treasurer)2022–2024Governance and finance oversight
Harvard Alumni AssociationBoard Member2018–2024Alumni governance
Various non-profitsBoard/ServiceNot specifiedServed on numerous non-profit boards

Board Governance

DimensionDetail
IndependenceBoard determined all directors except the CEO are independent; includes Dr. Kane
Committee Assignments (TriCo)CRA (Chair); IT/Cybersecurity (Member); Risk (Member)
2024 Committee MeetingsCRA: 4; IT/Cybersecurity: 4; Risk: 4; Audit: 11; Comp & Mgmt Succession: 6; Nominating & Corp Gov: 4
CRA Committee ScopeReviews CRA community development service performance and public comments
IT/Cybersecurity ScopeOversees IT strategy, information security, cybersecurity risk, and DR/BCP; quarterly updates required
Risk Committee ScopeOversees credit, liquidity, capital, IRR/market and operational risks; sets risk tolerances
Attendance2024 average attendance ~97%; no director <75% of Board/assigned committees
Executive SessionsIndependent directors hold executive sessions; independent lead director empowered
Lead Independent DirectorStructure annually reviewed; robust duties include agenda input, presiding, and advisor retention
Overboarding LimitMax four public company boards (including TriCo)
Ownership GuidelinesDirectors must hold ≥3x annual retainer within 5 years; compliance confirmed as of 12/31/24
Hedging/PledgingProhibited for directors and specified insiders

Fixed Compensation (Director)

ComponentAmountNotes
Annual Cash Retainer$52,500Non-employee director base retainer (2024)
Chair Fee (CRA)$7,500CRA committee chair retainer (2024)
Fees Earned (2024)$60,000Reported for Dr. Kane
Meeting Fees$0No additional per-meeting fees

Performance Compensation (Director)

Award TypeGrant DateShares/UnitsGrant Date Fair ValueVestingNotes
RSU (annual director grant)May 23, 20242,087$77,574Vests in full May 23, 2025RSUs sized off 30-day avg price; dividends accrue as RSU equivalents and vest with award

No performance-based metrics apply to director equity; director awards are time-based RSUs, not PSUs .

Other Directorships & Interlocks

CategoryDetail
Current public company boardsNone disclosed for Dr. Kane in the proxy
InterlocksNone disclosed involving Dr. Kane
Notable related-party relationships (Board context)Disclosed items involve other directors (e.g., property lease with entity associated with Director Leggio; legacy benefits for Director McGraw); none attributed to Dr. Kane

Expertise & Qualifications

  • Banking industry expertise across community, regional, and large institutions; retail banking leadership; strategic planning and execution .
  • Committee roles spanning CRA, cybersecurity/IT, and enterprise risk signal breadth in regulatory, technology, and risk oversight domains .
  • Deep Sacramento market knowledge and extensive community engagement .

Equity Ownership

ItemAmountNotes
Total Beneficial Ownership9,700 sharesAs of April 2, 2025 record date; includes RSUs vesting within 60 days
Ownership as % Outstanding<1%Denoted “* Less than 1%” in ownership table
RSUs Outstanding (12/31/2024)2,137 unitsDirector RSUs outstanding; number includes dividend equivalents in separate line contexts
RSUs Vesting Within 60 Days of Record Date2,154 unitsIncluded in beneficial ownership per SEC rules
Pledged/Hedged SharesNone permitted under policyHedging/pledging prohibited
Ownership Guideline StatusIn complianceAll directors met guidelines as of 12/31/2024

Governance Assessment

  • Board effectiveness and independence: Dr. Kane is independent, serves as CRA Chair and on Risk and IT/Cybersecurity, aligning her banking and retail expertise with regulatory, risk, and technology oversight; Board structure includes an empowered Lead Independent Director and independent-only committee composition .
  • Engagement and attendance: Strong 2024 attendance (97% aggregate; none below 75%), indicating active engagement across Board and committees relevant to her assignments .
  • Alignment and incentives: Director pay mix emphasizes equity via time-based RSUs (~$75k) plus modest cash retainer; CRA chair fee appropriately recognizes added oversight; no meeting fees that could incent quantity over quality of engagement .
  • Ownership and trading policies: She meets stock ownership guidelines; hedging and pledging prohibited, supporting alignment; director ownership requirement is 3x annual retainer within five years .
  • Conflicts/related-party exposure: No related-party transactions involving Dr. Kane disclosed; Nominating & Corporate Governance Committee oversees related-party reviews; any insider loans follow Regulation O and are on market terms .
  • Shareholder oversight signals: Say-on-pay support exceeded 97% in 2024, and clawback policies are in place for executives with strong governance practices across committees—positive for investor confidence even though these are executive-focused signals .

RED FLAGS

  • None observed for Dr. Kane: no disclosed related-party transactions, no attendance shortfalls, no overboarding, and no hedging/pledging. Director supplemental retirement and split-dollar life insurance programs apply to other legacy directors, not Dr. Kane; 2024 director deferred compensation participation was disclosed only for Directors Garen and Mariani .